Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach
Article in Therapeutics and Clinical Risk Management (July 2020)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Therapeutics and Clinical Risk Management (July 2020)
Article in Cells (June 2019)
Article in Annales de Dermatologie et de Vénéréologie (April 2018)